Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins

SARS-CoV-2 variants of concern (VOCs) have emerged worldwide, with implications on the spread of the pandemic. Characterizing the cross-reactivity of antibodies against these VOCs is necessary to understand the humoral response of non-hospitalized individuals previously infected with SARS-CoV-2, a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojjat Jodaylami, Maryam, Djaïleb, Abdelhadi, Ricard, Pierre, Lavallée, Étienne, Cellier-Goetghebeur, Stella, Parker, Megan-Faye, Coutu, Julien, Stuible, Matthew, Gervais, Christian, Durocher, Yves, Desautels, Florence, Cayer, Marie-Pierre, de Grandmont, Marie Joëlle, Rochette, Samuel, Brouard, Danny, Trottier, Sylvie, Boudreau, Denis, Pelletier, Joelle N., Masson, Jean-Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575961/
https://www.ncbi.nlm.nih.gov/pubmed/34750399
http://dx.doi.org/10.1038/s41598-021-00844-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575961/
https://www.ncbi.nlm.nih.gov/pubmed/34750399
http://dx.doi.org/10.1038/s41598-021-00844-z

Ejemplares similares